Permissions | Permits | Accreditations The CTC has the following permits from the State Trade Supervisory Office ( sGAA ) Hanover, which is responsible for drug monitoring in Lower Saxony, permits fro

Collaborations Within the Hannover Medical School: Leibniz Forschungslaboratorien für Biotechnologie und künstliche Organe (LEBAO) Klinik für Herz-, Thorax-, Transplantations- und Gefäßchirurgie (HTTG

Equipment Cell and tissue culture CliniMACSplus® → Cell separation (GMP-capable) CliniMACS Prodigy® platform → Automated cell processing (GMP-capable) NucleoCounter® NC-200 → Automated determination o

Founding The CTC was established as a central institution of the 'health care' Department PM2 of the Executive Committee of the Medical School Hannover on 01 September 2011. The CTC took over entirely

Data protection declaration for the use of forms (The confirmation link under this data protection declaration leads you to the forms) I have taken note of the following obligations, to be fully infor

Research In close cooperation with other Institutes of the MHH, we deal with a spectrum of different cell types as a therapeutic option for malignant and neurodegenerative diseases. T-cells CD20-CAR T

Working principles | Legal foundations The CTC operates in accordance with the following legal requirements: Parts 1 and 2 of the European Guidelines on Good Manufacturing Practice (GMP) the law regul

Head Dr. Stephan Klöß Phone: +49 511 532-7963 Administration Andrea Oppe Phone: +49 511 532-7960 Fax: +49 511 532-7961 oppe.anderea@mh-hannover.de

Profile of the Institute of Cell Therapeutics The Institute of Cell Therapeutics comprises two Departments, the GMP Development Unit (ATMP-GMPDU ) and the Cellular Therapy Center (CTC ) as the manufac